# Board Verdict: NERVE (promptops)

**Date:** 2026-04-11
**Reviewers:** Jensen Huang, Oprah Winfrey, Warren Buffett

---

## Points of Agreement

All three board members converge on these conclusions:

### 1. Solid Engineering, No Moat
- **Jensen:** "Excellent plumbing. But plumbing doesn't compound."
- **Warren:** "A competent engineer replicates this in 2-4 hours."
- **Oprah:** "The engineering decisions are sound. The architecture is thoughtful."

**Consensus:** NERVE is well-built commodity infrastructure with zero competitive advantage.

### 2. No Revenue Path
- **Jensen:** "Internal tool. Single-purpose. No extensibility."
- **Warren:** "This is overhead... a cost center."
- **Oprah:** Implicit agreement—no discussion of customers or monetization.

**Consensus:** NERVE generates no revenue and has no mechanism to generate revenue.

### 3. The Name Doesn't Match the Reality
- **Jensen:** "Why is this called 'promptops' when there are no prompts?"
- **Warren:** "The README quotes Jobs and Musk. That's not a moat. That's decoration."

**Consensus:** There's a credibility gap between aspiration and execution.

### 4. Process Was Expensive Relative to Output
- **Warren:** "Heavy process for light output... equivalent of hiring McKinsey to design your garage organization system."
- **Jensen:** "This is pre-MVP. The daemon is scaffolding for an intelligence layer that doesn't exist yet."

**Consensus:** 550 lines of bash didn't warrant multi-round synthetic debates.

---

## Points of Tension

### AI vs. No-AI Philosophy
| Position | Advocate |
|----------|----------|
| NERVE needs an AI layer to have any value | Jensen |
| NERVE works fine as reliable bash tooling | Warren (implicitly) |
| The essence (peace, reliability) matters more than implementation | Oprah |

**Jensen** wants LLMs in the verdict parser, predictive failure detection, and ML-prioritized queues.
**Warren** would rather kill the project than add complexity—"ship something someone will pay for."
**Oprah** cares about whether users feel welcomed and trust the product, regardless of implementation.

### Infrastructure vs. Product Debate
| Position | Advocate |
|----------|----------|
| Turn this into a platform ("Datadog for AI pipelines") | Jensen |
| Stop building infrastructure, build revenue-generating products | Warren |
| Make existing infrastructure accessible to more people | Oprah |

### Documentation Philosophy
| Position | Advocate |
|----------|----------|
| Clinical documentation is correct for infrastructure | Jensen (implicit) |
| Documentation excludes too many people | Oprah |
| Documentation is decoration; only ROI matters | Warren |

---

## Scores Summary

| Reviewer | Score | Key Critique |
|----------|-------|--------------|
| Jensen Huang | 4/10 | Zero AI leverage, no compounding moat |
| Oprah Winfrey | 6/10 | Technically sound but excludes newcomers |
| Warren Buffett | 4/10 | No revenue path, commodity infrastructure |

**Average Score: 4.7/10**

---

## Overall Verdict: HOLD

**Rationale:**

NERVE is neither ready to proceed as-is nor bad enough to reject outright. The infrastructure is competent but lacks:
1. Competitive differentiation
2. Revenue potential
3. The AI capabilities its name implies

The investment in process (multi-persona debates) exceeded the complexity of the output. However, the foundation exists for something more valuable if the conditions below are met.

---

## Conditions for Proceeding

To move from HOLD to PROCEED, the team must address:

### Mandatory (Pick One Path)

**Path A: Make It a Product**
- [ ] Define external customer segment
- [ ] Build API/SDK for programmatic access
- [ ] Establish pricing model
- [ ] Ship one paying customer

**Path B: Add the AI**
- [ ] LLM-powered verdict parsing (understand failures, not just pattern-match)
- [ ] Execution history persistence for training data
- [ ] At minimum one predictive capability (failure prediction, prioritization, or auto-remediation)
- [ ] Rename if AI doesn't ship: "promptops" with zero prompts is a credibility gap

**Path C: Validate Internal ROI**
- [ ] Document baseline metrics before NERVE (incident frequency, cost per failure)
- [ ] Document post-NERVE metrics
- [ ] Prove that NERVE prevented X failures worth $Y
- [ ] If ROI is positive, continue as internal tooling (but stop expensive process theater)

### Recommended Regardless of Path
- [ ] Add human introduction to documentation explaining WHY this exists
- [ ] Reduce process overhead for internal tooling (one builder shipping > two personas debating)
- [ ] Do not build another internal tool until one customer-facing product ships

---

## Final Note

As Warren observed: *"Show me the incentive and I'll show you the outcome."*

The current incentive is to build interesting infrastructure. The outcome is interesting infrastructure. To change the outcome, change the incentive.

**Next Review:** After one condition path is complete.

---

*Consolidated by: Board Synthesis Process*
*Great Minds Agency*
